Bausch Health Companies Inc. (BHC)
NYSE: BHC · Real-Time Price · USD
5.17
+0.06 (1.17%)
Jun 9, 2026, 4:00 PM EDT - Market closed
Bausch Health Companies Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 11,881 | 10,266 | 9,625 | 8,757 | 8,124 | 8,434 | |
Revenue Growth (YoY) | 30.89% | 6.66% | 9.91% | 7.79% | -3.68% | 5.07% |
Cost of Revenue | 3,463 | 3,013 | 2,782 | 2,559 | 2,364 | 2,394 |
Gross Profit | 8,418 | 7,253 | 6,843 | 6,198 | 5,760 | 6,040 |
Selling, General & Admin | 3,928 | 3,438 | 3,296 | 2,917 | 2,625 | 2,624 |
Depreciation & Amortization Expenses | 1,130 | 1,001 | 1,077 | 1,077 | 1,215 | 1,375 |
Research & Development | 734.11 | 629 | 616 | 604 | 529 | 465 |
Other Operating Expenses | 1,835 | 372 | 308 | 637 | 937 | 1,126 |
Total Operating Expenses | 7,628 | 5,440 | 5,297 | 5,235 | 5,306 | 5,590 |
Operating Income | 789.92 | 1,813 | 1,546 | 963 | 454 | 450 |
Interest Income | 53.76 | 48 | 33 | 26 | 14 | 7 |
Interest Expense | -1,900 | -1,604 | -1,388 | -1,328 | -1,464 | -1,426 |
Other Non-Operating Income (Expense) | 142.58 | 110 | -24 | -51 | 867 | -55 |
Total Non-Operating Income (Expense) | -1,704 | -1,446 | -1,379 | -1,353 | -583 | -1,474 |
Pretax Income | -913.79 | 367 | 167 | -390 | -129 | -1,024 |
Provision for Income Taxes | -299.37 | -247 | -239 | -221 | -83 | 87 |
Net Income | -1,213 | 120 | -72 | -611 | -212 | -937 |
Minority Interest in Earnings | 30.53 | 37 | 26 | 19 | -13 | -11 |
Net Income to Common | -1,183 | 157 | -46 | -592 | -225 | -948 |
Shares Outstanding (Basic) | 372 | 371 | 368 | 365 | 362 | 359 |
Shares Outstanding (Diluted) | 375 | 375 | 368 | 365 | 362 | 359 |
Shares Change (YoY) | 1.49% | 1.90% | 0.85% | 0.80% | 0.86% | 1.10% |
EPS (Basic) | -3.38 | 0.42 | -0.13 | -1.62 | -0.62 | -2.64 |
EPS (Diluted) | -3.38 | 0.42 | -0.13 | -1.62 | -0.62 | -2.64 |
Free Cash Flow | 755.75 | 730.75 | 878 | 616.61 | -946 | 1,157 |
Free Cash Flow Growth | 3.42% | -16.77% | 42.39% | - | - | 43.02% |
Free Cash Flow Per Share | 2.02 | 1.95 | 2.39 | 1.69 | -2.61 | 3.22 |
Gross Margin | 70.85% | 70.65% | 71.10% | 70.78% | 70.90% | 71.61% |
Operating Margin | 6.65% | 17.66% | 16.06% | 11.00% | 5.59% | 5.34% |
Profit Margin | -10.21% | 1.17% | -0.75% | -6.98% | -2.61% | -11.11% |
FCF Margin | 6.36% | 7.12% | 9.12% | 7.04% | -11.64% | 13.72% |
EBITDA | 1,660 | 2,693 | 2,429 | 1,917 | 1,848 | 2,002 |
EBITDA Margin | 13.97% | 26.23% | 25.24% | 21.89% | 22.75% | 23.74% |
EBIT | 789.92 | 1,813 | 1,546 | 963 | 454 | 450 |
EBIT Margin | 6.65% | 17.66% | 16.06% | 11.00% | 5.59% | 5.34% |
Effective Tax Rate | 32.76% | -67.30% | -143.11% | 56.67% | 64.34% | -8.50% |